A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism

At present, neither basic research nor clinical studies have revealed the exact biological functions or mechanisms of action of individual oligosaccharides during development or in adulthood. Thus, it remains largely unknown whether human milk oligosaccharides could serve as effective therapeutics f...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:mBio Ročník 15; číslo 4; s. e0029824
Hlavní autoři: Schalich, Kasey M., Buendia, Matthew A., Kaur, Harpreet, Choksi, Yash A., Washington, M. Kay, Codreanu, Gabriela S., Sherrod, Stacy D., McLean, John A., Peek, Jr, Richard M., Acra, Sari A., Townsend, Steven D., Yan, Fang
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States American Society for Microbiology 10.04.2024
Témata:
ISSN:2150-7511, 2161-2129, 2150-7511
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:At present, neither basic research nor clinical studies have revealed the exact biological functions or mechanisms of action of individual oligosaccharides during development or in adulthood. Thus, it remains largely unknown whether human milk oligosaccharides could serve as effective therapeutics for gastrointestinal-related diseases. Results from the present study uncover 2′-FL-driven alterations in bacterial metabolism and identify novel B. infantis -secreted metabolites following the consumption of 2′-FL, including pantothenol. This work further demonstrates a previously unrecognized role of pantothenate in significantly protecting the intestinal barrier against oxidative stress and mitigating colitis in adult mice. Remarkably, 2′-FL-enhanced bacterial metabolic pathways are found to be dysregulated in the fecal microbiota of ulcerative colitis patients. These novel metabolic pathways underlying the bioactivities of 2′-FL may lay a foundation for applying individual oligosaccharides for prophylactic intervention for diseases associated with impaired intestinal homeostasis.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
The authors declare no conflict of interest.
ISSN:2150-7511
2161-2129
2150-7511
DOI:10.1128/mbio.00298-24